The Relationship Between Autism Spectrum Disorder and Purine Metabolism Enzyme Levels
Abstract
Background and Aim: This study aimed to compare the serum levels of purine metabolism–related enzymes—xanthine oxidase (XO), 5′-nucleotidase (5′NT), and adenosine deaminase (ADA)—in children diagnosed with autism spectrum disorder (ASD) and healthy controls. By contributing to the understanding of the biochemical basis of ASD, the study sought to provide a scientific foundation for biomarker development. Materials and Methods: A total of 80 children were included in the study: 40 children diagnosed with ASD according to DSM-5 criteria and 40 healthy controls. Serum levels of 5′NT, ADA, and XO were analyzed using spectrophotometric methods. Results: XO levels were found to be significantly lower in the ASD group compared with the control group (p < 0.001). Although no statistically significant differences were observed between the groups in terms of ADA and 5′NT levels (p = 0.095 and p = 0.228, respectively), ADA activity tended to be lower and 5′NT activity higher in the ASD group. Additionally, no statistically significant correlations were detected among enzyme levels in either group (p > 0.05). Conclusion: Although not statistically significant for all parameters, the findings of higher 5′NT activity, lower ADA activity, and significantly reduced XO activity in the ASD group suggest a possible disturbance in purine metabolism and a potential accumulation of adenosine.
Keywords
autism spectrum disorder, adenosine deaminase, 5'-nucleotidase, xanthine oxidase, purine metabolism
Ethical Statement
References
- Zeidan J, Fombonne E, Scorah J, Ibrahim A, Durkin MS, Saxena S, et al. Global prevalence of autism: A systematic review update. Autism Res. 2022;15(5):778-790.
- Taylor MJ, Rosenqvist MA, Larsson H, Gillberg C, D’Onofrio BM, Lichtenstein P, et al. Etiology of autism spectrum disorders and autistic traits over time. JAMA Psychiatry. 2020;77(9):936-943.
- Meguid NA, Dardir AA, Abdel-Raouf ER, Hashish A. Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation. Biol Trace Elem Res. 2011;143(1):58-65.
- Bottini N, De Luca D, Saccucci P, Fiumara A, Elia M, Porfirio MC, et al. Autism: evidence of association with adenosine deaminase genetic polymorphism. Neurogenetics. 2001;3(2):111-113.
- Mahmood LA, Al Saadi R, Matthews L. Dietary and antioxidant therapy for autistic children: Does it really work? Arch Med Health Sci. 2018;6(1):73-80.
- Halliwell B, Gutteridge JM. Free radicals in biology and medicine. Oxford: Oxford University Press; 2015.
- Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther. 2021;6:162.
- Coppi E, Dettori I, Cherchi F, Bulli I, Venturini M, Pedata F, et al. New insight into the role of adenosine in demyelination, stroke and neuropathic pain. Front Pharmacol. 2021;11:625662.
- Stevens B, Porta S, Haak LL, Gallo V, Fields RD. Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron. 2002;36(5):855-868.
- Stubbs G, Litt M, Lis E, Jackson R, Voth W, Lindberg A, et al. Adenosine deaminase activity decreased in autism. J Am Acad Child Psychiatry. 1982;21(1):71-74.